Willow Biosciences Inc.Willow Biosciences Inc.Willow Biosciences Inc.

Willow Biosciences Inc.

No trades
See on Supercharts
Market capitalization
‪8.36 M‬USD
−0.0792USD
‪−9.83 M‬USD
‪884.27 K‬USD
‪90.05 M‬
Beta (1Y)
1.18

About Willow Biosciences Inc.

CEO
Chris Savile
Headquarters
Calgary
Employees (FY)
19
Founded
1981
FIGI
BBG000H7DXB6
Willow Biosciences, Inc. is a biotechnology company, which engages in the research, development, and commercialization of plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. It operates through the Canada and The Rest of the World, and Unites States geographical segments. The company was founded on April 15, 1981 and is headquartered in Calgary, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CANSF is 0.0644 USD — it has increased by 1.02% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Willow Biosciences Inc. stocks are traded under the ticker CANSF.
Willow Biosciences Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
CANSF stock is 2.18% volatile and has beta coefficient of 1.18. Check out the list of the most volatile stocks — is Willow Biosciences Inc. there?
Willow Biosciences Inc. revenue for the last quarter amounts to ‪1.58 K‬ USD despite the estimated figure of ‪315.28 K‬ USD. In the next quarter revenue is expected to reach ‪316.24 K‬ USD.
Yes, you can track Willow Biosciences Inc. financials in yearly and quarterly reports right on TradingView.
CANSF stock has fallen by 1.60% compared to the previous week, the month change is a 1.51% fall, over the last year Willow Biosciences Inc. has showed a 38.62% decrease.
CANSF net income for the last quarter is ‪−1.83 M‬ USD, while the quarter before that showed ‪−1.64 M‬ USD of net income which accounts for −11.37% change. Track more Willow Biosciences Inc. financial stats to get the full picture.
Today Willow Biosciences Inc. has the market capitalization of ‪8.34 M‬, it has increased by 6.90% over the last week.
No, CANSF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CANSF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Willow Biosciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
CANSF reached its all-time high on Apr 21, 2017 with the price of 4.0000 USD, and its all-time low was 0.0012 USD and was reached on Nov 8, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 19.00 employees. See our rating of the largest employees — is Willow Biosciences Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Willow Biosciences Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Willow Biosciences Inc. stock shows the sell signal. See more of Willow Biosciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Willow Biosciences Inc. EBITDA is ‪−8.80 M‬ USD, and current EBITDA margin is −992.06%. See more stats in Willow Biosciences Inc. financial statements.